SourceSTAT News
STAT+: FDA discloses reasons for rejecting Summit drug
The FDA published its complete response letter to Summit Therapeutics explaining why it rejected the biotech's closely watched lung cancer…
See the latestThe FDA published its complete response letter to Summit Therapeutics explaining why it rejected the biotech's closely watched lung cancer…
See the latest